Northwest & Ethical Investments L.P. Bausch Health Companies Inc. Transaction History
Northwest & Ethical Investments L.P.
- $4.03 Trillion
- Q2 2025
A detailed history of Northwest & Ethical Investments L.P. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 43,272 shares of BHC stock, worth $260,064. This represents 0.01% of its overall portfolio holdings.
Number of Shares
43,272
Previous 89,848
51.84%
Holding current value
$260,064
Previous $583 Million
50.52%
% of portfolio
0.01%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding BHC
# of Institutions
251Shares Held
243MCall Options Held
2.44MPut Options Held
8.42M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$209 Million2.99% of portfolio
-
Goldentree Asset Management LP New York, NY34.3MShares$206 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$197 Million11.35% of portfolio
-
Nomura Holdings Inc Tokyo, M021.5MShares$129 Million0.31% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$78.1 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.17B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...